title: [Treatment of pneumococcal meningitis with dexamethasone].
abstract: Our aim was two compare two different dexamethasone administration schedules in pneumococcal meningitis: short course (48h) and long course (96h) treatment. We diagnosed 18 pneumococcal meningitis treated with the two different schedules. We found a statistically significant longer duration of primary fever in patients who received dexamethasone for two days. We found no differences in the appearance of secondary fever, or in the development of severe neurological handicaps, or death between the two groups. We conclude that they are no significant differences between the two treatment schedules and that there is a need for developing early prognostic markers and adjuvant therapies that improve the outcome of patients with pneumococcal meningitis.
authors.affiliation: Servicio de Pediatría, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona, Barcelona, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Felipe Rucián
authors.forename: G
authors.initials: G
authors.lastname: García Del Cerro
authors.forename: F
authors.initials: F
authors.lastname: Coll Usandizaga
authors.forename: M
authors.initials: M
authors.lastname: Tobeña Rué
authors.forename: X
authors.initials: X
authors.lastname: Martínez Gómez
authors.forename: F A
authors.initials: FA
authors.lastname: Moraga-Llop
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D003907:Dexamethasone / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008586:Meningitis, Pneumococcal / Q000188:drug therapy*; D012189:Retrospective Studies
chemical_list: D000893:Anti-Inflammatory Agents; D003907:Dexamethasone